£57.02

Academic Press Neurochemical Aspects of Alzheimer's Disease: Risk Factors, Pathogenesis, Biomarkers, and Potential Treatment Strategies

Price data last checked 57 day(s) ago - refreshing...

View at Amazon

Price History & Forecast

Last 34 days • 34 data points (No recent data available)

Historical
Generating forecast...
£62.64 £56.46 £57.81 £59.16 £60.50 £61.85 £63.20 25 January 2026 02 February 2026 10 February 2026 18 February 2026 27 February 2026

Price Distribution

Price distribution over 34 days • 3 price levels

Days at Price
Current Price
10 days · current 19 days 5 days 0 5 10 14 19 £57 £60 £63 Days at Price

Price Analysis

Most common price: £60 (19 days, 55.9%)

Price range: £57 - £63

Price levels: 3 different prices over 34 days

Description

Product Description Neurochemical Aspects of Alzheimer's Disease provides a comprehensive overview of molecular aspects of risk factors, pathogenesis, biomarkers, and therapeutic strategies. The book focuses on molecular mechanisms and signal transduction processes associated with the pathogenesis, biomarkers, and therapeutic strategies of AD. The comprehensive and cutting edge information in this monograph may not only help in early detection of AD, but also promote discovery of new drugs to treat this chronic disease. Chapters discuss involvement of neural membrane phospholipids, sphingolipids, and cholesterol-derived lipid mediators, abnormal APP processing, and nucleic acid damage, risk factors, biomarker, and therapeutic strategies of Alzheimer's disease. This book is written for neurologists, neuroscientists, neurochemists, neuropharmacologists, and clinicianswho are interested in molecular mechanisms associated with the pathogenesis of age-related neurological disorders. Review A comprehensive overview of the molecular aspects of Alzheimer's disease, including risk factors, pathogenesis, biomarkers, and therapeutic strategies About the Author Akhlaq A. Farooqui is a leader in the field of signal transduction, brain phospholipases A2, bioactive ether lipid metabolism, polyunsaturated fatty acid metabolism, glycerophospholipid-, sphingolipid-, and cholesterol-derived lipid mediators, glutamate-induced neurotoxicity and modulation of signal transduction by phytochemicals. He has published more than 200 hundred papers, authored 11 monographs: Glycerophospholipids in Brain: Phospholipase A2 in Neurological Disorders (2007); Neurochemical Aspects of Excitotoxicity (2008); Metabolism and Functions of Bioactive Ether Lipids in Brain (2008); and Hot Topics in Neural Membrane Lipidology (2009); Beneficial Effects of Fish Oil in Human Brain (2009); Neurochemical Aspects of Neurotraumatic and Neurodegenerative Diseases (2010); Lipid Mediators and their Metabolism in the Brain (2011); Phytochemicals, Signal Transduction, and Neurological Disorders (2012); Metabolic Syndrome: An Important Risk Factor for Stroke, Alzheimer Disease, Depression (2013); Inflammation and Oxidative Stress in Neurological Disorders (2014); High Calorie Diet and the Human Brain: Consequences of Long Term Consumption (2015); Therapeutic Potentials of Curcumin for Alzheimer Disease (2016). All monographs are published by Springer, New York. Akhlaq A. Farooqui has edited 10 books published by Wiley Blackwell Publishing Company, New York; Nova Science Publisher, New York; Bentham Science Publishers, Dubai, and Elsevier, San Diego, CA.

Product Specifications

Barcode

No barcode data available

Similar Products You Might Like

Molecular Mechanisms of Dementia: Biomarkers, Neurochemistry, and Therapy
98% match

Molecular Mechanisms of Dementia: Biomarkers, Neurochemistry, and Therapy

Academic Press

£98.89 08 Mar 2026
Molecular Aspects of Neurodegeneration, Neuroprotection, and Regeneration in Neurological Disorders
97% match

Molecular Aspects of Neurodegeneration, Neuroprotection, and Regeneration in Neurological Disorders

Academic Press

£101.89 26 Jan 2026
Neuroinflammation, Resolution, and Neuroprotection in the Brain
97% match

Neuroinflammation, Resolution, and Neuroprotection in the Brain

Academic Press

£101.29 09 Mar 2026
Neurochemical Aspects of Neurotraumatic and Neurodegenerative Diseases
97% match

Neurochemical Aspects of Neurotraumatic and Neurodegenerative Diseases

Springer

£179.99 22 Jan 2026
Ischemic and Traumatic Brain and Spinal Cord Injuries: Mechanisms and Potential Therapies
97% match

Ischemic and Traumatic Brain and Spinal Cord Injuries: Mechanisms and Potential Therapies

Academic Press

£83.95 25 Feb 2026
Beneficial Effects of Fish Oil on Human Brain
96% match

Beneficial Effects of Fish Oil on Human Brain

Springer

£135.10 27 Jan 2026
Lipid Mediators and Their Metabolism in the Brain
96% match

Lipid Mediators and Their Metabolism in the Brain

Springer

£146.40 28 Jan 2026
Neurochemical Aspects of Neurotraumatic and Neurodegenerative Diseases
95% match

Neurochemical Aspects of Neurotraumatic and Neurodegenerative Diseases

Springer

£147.75 27 Jan 2026
Metabolic Syndrome and Neurological Disorders
94% match

Metabolic Syndrome and Neurological Disorders

Wiley

£150.29 18 Apr 2026
Alzheimer's Disease: Targets for New Clinical Diagnostic and Therapeutic Strategies (Frontiers in Neuroscience)
94% match

Alzheimer's Disease: Targets for New Clinical Diagnostic and Therapeutic Strategies (Frontiers in Neuroscience)

CRC Press

£87.80 09 Mar 2026
Neurodegenerative Diseases: Clinical Aspects, Molecular Genetics and Biomarkers
94% match

Neurodegenerative Diseases: Clinical Aspects, Molecular Genetics and Biomarkers

Springer

£89.02 09 Mar 2026
Pharmacological Treatment of Alzheimer's Disease: Molecular and Neurobiological Foundations
94% match

Pharmacological Treatment of Alzheimer's Disease: Molecular and Neurobiological Foundations

Wiley

£207.59 10 Feb 2026
Current Hypotheses and Research Milestones in Alzheimer's Disease
94% match

Current Hypotheses and Research Milestones in Alzheimer's Disease

Springer

£50.17 10 Mar 2026
Drug Discovery Approaches for the Treatment of Neurodegenerative Disorders: Alzheimer's Disease
94% match

Drug Discovery Approaches for the Treatment of Neurodegenerative Disorders: Alzheimer's Disease

Academic Press

£52.49 21 Feb 2026
Neuroglia in Neurodegenerative Diseases: 1175 (Advances in Experimental Medicine and Biology, 1175)
94% match

Neuroglia in Neurodegenerative Diseases: 1175 (Advances in Experimental Medicine and Biology, 1175)

Springer

£123.23 16 Apr 2026
Neuroglia in Neurodegenerative Diseases: 1175 (Advances in Experimental Medicine and Biology, 1175)
94% match

Neuroglia in Neurodegenerative Diseases: 1175 (Advances in Experimental Medicine and Biology, 1175)

Springer

£122.05 09 Mar 2026
Alzheimer's Disease: Cellular and Molecular Aspects of Amyloid beta: 38 (Subcellular Biochemistry)
94% match

Alzheimer's Disease: Cellular and Molecular Aspects of Amyloid beta: 38 (Subcellular Biochemistry)

Springer

£165.89 18 Apr 2026
Neuroprotection in Alzheimer's Disease
94% match

Neuroprotection in Alzheimer's Disease

Academic Press

£85.71 11 Mar 2026
Molecular Basis of Neuropsychiatric Disorders: from Bench to Bedside (Volume 167) (Progress in Molecular Biology and Translational Science, Volume 167)
94% match

Molecular Basis of Neuropsychiatric Disorders: from Bench to Bedside (Volume 167) (Progress in Molecular Biology and Translational Science, Volume 167)

Academic Press

£116.56 13 Apr 2026
Research Progress in Alzheimer's Disease And Dementia: 1: v. 1: Volume 1
94% match

Research Progress in Alzheimer's Disease And Dementia: 1: v. 1: Volume 1

£85.57 01 Mar 2026
Molecular Mechanisms of Neurodegenerative Diseases (Contemporary Clinical Neuroscience)
94% match

Molecular Mechanisms of Neurodegenerative Diseases (Contemporary Clinical Neuroscience)

Humana

£169.22 22 Jan 2026
The Neuroscience of Aging
94% match

The Neuroscience of Aging

Academic Press

£279.70 11 Apr 2026
A New Era in Alzheimer's Research: Pathogenesis, Prevention, and Treatment
93% match

A New Era in Alzheimer's Research: Pathogenesis, Prevention, and Treatment

Academic Press

£120.98 30 Jan 2026
Multi-Factorial Approach as a Therapeutic Strategy for the Management of Alzheimer’s Disease
93% match

Multi-Factorial Approach as a Therapeutic Strategy for the Management of Alzheimer’s Disease

£193.55 14 Jan 2026